Tenaya Therapeutics (TNYA) Current Assets (2020 - 2026)

Tenaya Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $96.6 million for Q1 2026.

• In Q1 2026, Current Assets rose 2.2% year-over-year to $96.6 million; the TTM figure through Mar 2026 stood at $96.6 million (up 2.2% YoY), while the FY2025 annual figure was $105.6 million, up 56.71% from the prior year.
• Current Assets was $96.6 million for Q1 2026 at Tenaya Therapeutics, down from $105.6 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $213.8 million in Q1 2022 to a low of $61.2 million in Q3 2025.
• Historically, Current Assets has averaged $123.7 million across 5 years, with a median of $111.6 million in 2023.
• Biggest YoY gain for Current Assets was 64.01% in 2022; the steepest drop was 44.85% in 2022.
• A 5-year view of Current Assets shows it stood at $193.8 million in 2022, then slumped by 42.41% to $111.6 million in 2023, then plunged by 39.62% to $67.4 million in 2024, then jumped by 56.71% to $105.6 million in 2025, then dropped by 8.55% to $96.6 million in 2026.
• The last three Current Assets figures came in at $96.6 million (Q1 2026), $105.6 million (Q4 2025), and $61.2 million (Q3 2025), per Business Quant data.